Skip to main content

Table 2 Number of individuals with identified 20 chronic conditions (CCs), reimbursed prescribed drugs and associated costs.

From: Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources

    

Cost per

 
  

Prevalence

 

patient

Total Cost

Chronic Condition

Individuals

(per 1000)

Packages

(€)

(€)

Cardiovascular diseases

1199325

226.1

35,052,888

323.8

388,332,400

Rheumatologic conditions

463439

87.4

3,544,925

62.6

28,991,584

Chronic respiratory illnesses

251500

47.4

3,093,147

315.0

79,233,729

Diabetes

234117

44.1

4,565,308

192.6

45,100,938

Thyroid disorders

232852

43.9

1,906,099

23.5

5,477,555

Psychiatric diseases

202575

38.2

2,832,875

289.5

58,636,881

Epilepsy

99997

18.9

1,836,803

262.6

26,261,613

Paget's disease/osteoporosis chronic conditions

97167

18.3

991,775

262.8

25,532,022

Glaucoma

87793

16.5

1,571,032

229.2

20,120,303

Malignancies

77791

14.7

1,008,838

1,073.0

83,468,370

Parkinson's disease

23836

4.5

634,129

579.2

13,805,687

Crohn's and Ulcerative colitis

20763

3.9

384,769

416.5

8,647,390

Migraine

20354

3.8

349,518

382.9

7,794,343

Psoriasis

11735

2.2

156,922

180.1

2,113,543

Alzheimer's disease

8220

1.5

93,896

1,174.8

9,656,930

HIV/AIDS

5170

1.0

54,470

703.1

3,635,284

Chronic renal diseases

4271

0.8

60,225

2,218.3

9,474,249

Cirrhosis

3989

0.8

87,385

443.1

1,767,496

Chronic hepatitis and selective malignancies

2633

0.5

77,672

6,058.6

15,952,232

Tuberculosis

2093

0.4

32,552

113.3

237,101

  1. Lazio region, Italy.